R

Rani Therapeutics Holdings, Inc. (RANI)

NGM – Real vaqt narxi. Valyuta: USD

0.80

+0.02 (2.27%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

0.79

-0.01 (-1.22%)

Bozordan keyin: Aug 12, 2026, 4:59 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

R

Rani Therapeutics Holdings, Inc. (RANI)

NGM – Real vaqt narxi. Valyuta: USD

0.80

+0.02 (2.27%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

0.79

-0.01 (-1.22%)

Bozordan keyin: Aug 12, 2026, 4:59 PM EDT

10.08.2026

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company's management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below:

Videolar

No Data

There is no data to display

Press-relizlar

10.08.2026

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company's management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below:

10.08.2026

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company's management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below:

Videolar

No Data

There is no data to display

Press-relizlar

10.08.2026

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company's management team will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference. Details below:

Search stocks

Rani Therapeutics Holdings, Inc. (RANI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Rani Therapeutics Holdings, Inc. (RANI)

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Videolar

No Data

Press-relizlar

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Videolar

No Data

Press-relizlar

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference